The core activity of MRGN Advisors is healthcare consulting, particularly in the areas of pharmaceuticals, biologics, medical technology, and digital health. The company provides strategic consulting, tailored recommendations, and effective implementation of solutions for CEOs, boards of directors, investors, and companies in the healthcare industry.
AI-generated
Offering
Products & services
Industry:Management Consulting
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Consulting for CEOs, supervisory boards and investors; customized recommendations, strategic thinking and effective execution across product development, market access, manufacturing footprint, launch and life cycle management.
Health Care
Health care advisory for infrastructure projects in Switzerland, including the set-up of specialized surgical centers and clinics.
Pharmaceuticals
Pharmaceutical advisory for oncology, cardiovascular, central nervous system, dermatology and allergology, leveraging sector experience to anticipate trends and translate them into opportunities.
Biologics
Biologics advisory covering innovation, business development and partnering, funding and access strategies, based on healthcare investment and operations experience.
Vaccines
Vaccines advisory across research, development, manufacturing, regulatory, market access and immunization policy strategies.
Med Tech
Med tech advisory for investors and companies, including innovation, partnering, financing and market access strategies.
Digital Health
Digital health advisory for investors and healthcare companies seeking opportunities in healthcare IT.
Comparisons
MRGN Advisors Sàrl in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank MRGN Advisors Sàrl by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once MRGN Advisors Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.